No Cover Image

Journal article 1011 views

Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial

KD Jones, B Hünten-Kirsch, AM Laving, CW Munyi, M Ngari, J Mikusa, MM Mulongo, D Odera, HS Nassir, M Timbwa, M Owino, G Fegan, SH Murch, PB Sullivan, JO Warner, JA Berkley, Greg Fegan

BMC Medicine, Volume: 12, Issue: 1

Swansea University Author: Greg Fegan

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1186/s12916-014-0133-2

Abstract

Novel use of a medicine used in IBD in kids with malnutrition

Published in: BMC Medicine
ISSN: 1741-7015
Published: 2014
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa26562
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2016-03-03T01:58:20Z
last_indexed 2018-02-09T05:08:40Z
id cronfa26562
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2016-10-25T15:20:55.8005836</datestamp><bib-version>v2</bib-version><id>26562</id><entry>2016-03-02</entry><title>Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial</title><swanseaauthors><author><sid>a9005418b89918776f3d8895ba42e850</sid><firstname>Greg</firstname><surname>Fegan</surname><name>Greg Fegan</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-03-02</date><deptcode>FGMHL</deptcode><abstract>Novel use of a medicine used in IBD in kids with malnutrition</abstract><type>Journal Article</type><journal>BMC Medicine</journal><volume>12</volume><journalNumber>1</journalNumber><publisher/><issnElectronic>1741-7015</issnElectronic><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-12-31</publishedDate><doi>10.1186/s12916-014-0133-2</doi><url>http://europepmc.org/abstract/med/25189855</url><notes/><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-10-25T15:20:55.8005836</lastEdited><Created>2016-03-02T11:28:35.4425906</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>KD</firstname><surname>Jones</surname><order>1</order></author><author><firstname>B</firstname><surname>H&#xFC;nten-Kirsch</surname><order>2</order></author><author><firstname>AM</firstname><surname>Laving</surname><order>3</order></author><author><firstname>CW</firstname><surname>Munyi</surname><order>4</order></author><author><firstname>M</firstname><surname>Ngari</surname><order>5</order></author><author><firstname>J</firstname><surname>Mikusa</surname><order>6</order></author><author><firstname>MM</firstname><surname>Mulongo</surname><order>7</order></author><author><firstname>D</firstname><surname>Odera</surname><order>8</order></author><author><firstname>HS</firstname><surname>Nassir</surname><order>9</order></author><author><firstname>M</firstname><surname>Timbwa</surname><order>10</order></author><author><firstname>M</firstname><surname>Owino</surname><order>11</order></author><author><firstname>G</firstname><surname>Fegan</surname><order>12</order></author><author><firstname>SH</firstname><surname>Murch</surname><order>13</order></author><author><firstname>PB</firstname><surname>Sullivan</surname><order>14</order></author><author><firstname>JO</firstname><surname>Warner</surname><order>15</order></author><author><firstname>JA</firstname><surname>Berkley</surname><order>16</order></author><author><firstname>Greg</firstname><surname>Fegan</surname><order>17</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2016-10-25T15:20:55.8005836 v2 26562 2016-03-02 Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial a9005418b89918776f3d8895ba42e850 Greg Fegan Greg Fegan true false 2016-03-02 FGMHL Novel use of a medicine used in IBD in kids with malnutrition Journal Article BMC Medicine 12 1 1741-7015 31 12 2014 2014-12-31 10.1186/s12916-014-0133-2 http://europepmc.org/abstract/med/25189855 COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University 2016-10-25T15:20:55.8005836 2016-03-02T11:28:35.4425906 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine KD Jones 1 B Hünten-Kirsch 2 AM Laving 3 CW Munyi 4 M Ngari 5 J Mikusa 6 MM Mulongo 7 D Odera 8 HS Nassir 9 M Timbwa 10 M Owino 11 G Fegan 12 SH Murch 13 PB Sullivan 14 JO Warner 15 JA Berkley 16 Greg Fegan 17
title Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
spellingShingle Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
Greg Fegan
title_short Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
title_full Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
title_fullStr Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
title_full_unstemmed Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
title_sort Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial
author_id_str_mv a9005418b89918776f3d8895ba42e850
author_id_fullname_str_mv a9005418b89918776f3d8895ba42e850_***_Greg Fegan
author Greg Fegan
author2 KD Jones
B Hünten-Kirsch
AM Laving
CW Munyi
M Ngari
J Mikusa
MM Mulongo
D Odera
HS Nassir
M Timbwa
M Owino
G Fegan
SH Murch
PB Sullivan
JO Warner
JA Berkley
Greg Fegan
format Journal article
container_title BMC Medicine
container_volume 12
container_issue 1
publishDate 2014
institution Swansea University
issn 1741-7015
doi_str_mv 10.1186/s12916-014-0133-2
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
url http://europepmc.org/abstract/med/25189855
document_store_str 0
active_str 0
description Novel use of a medicine used in IBD in kids with malnutrition
published_date 2014-12-31T03:31:54Z
_version_ 1763751298817064960
score 11.037056

Similar Items